Literature DB >> 23800967

β-endorphin via the delta opioid receptor is a major factor in the incubation of cocaine craving.

Yahav Dikshtein1, Royi Barnea, Noam Kronfeld, Elad Lax, Ilana Roth-Deri, Alexander Friedman, Iris Gispan, Einat Elharrar, Sarit Levy, Moshe Ben-Tzion, Gal Yadid.   

Abstract

Cue-induced cocaine craving intensifies, or 'incubates', during the first few weeks of abstinence and persists over extended periods of time. One important factor implicated in cocaine addiction is the endogenous opioid β-endorphin. In the present study, we examined the possible involvement of β-endorphin in the incubation of cocaine craving. Rats were trained to self-administer cocaine (0.75 mg/kg, 10 days, 6 h/day), followed by either a 1-day or a 30-day period of forced abstinence. Subsequent testing for cue-induced cocaine-seeking behavior (without cocaine reinforcement) was performed. Rats exposed to the drug-associated cue on day 1 of forced abstinence demonstrated minimal cue-induced cocaine-seeking behavior concurrently with a significant increase in β-endorphin release in the nucleus accumbens (NAc). Conversely, exposure to the cue on day 30 increased cocaine seeking, while β-endorphin levels remained unchanged. Intra-NAc infusion of an anti-β-endorphin antibody (4 μg) on day 1 increased cue-induced cocaine seeking, whereas infusion of a synthetic β-endorphin peptide (100 ng) on day 30 significantly decreased cue response. Both intra-NAc infusions of the δ opioid receptor antagonist naltrindole (1 μg) on day 1 and naltrindole together with β-endorphin on day 30 increased cue-induced cocaine-seeking behavior. Intra-NAc infusion of the μ opioid receptor antagonist CTAP (30 ng and 3 μg) had no behavioral effect. Altogether, these results demonstrate a novel role for β-endorphin and the δ opioid receptor in the development of the incubation of cocaine craving.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23800967      PMCID: PMC3799071          DOI: 10.1038/npp.2013.155

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  39 in total

1.  Attenuated beta endorphin response to acute stress is associated with smoking relapse.

Authors:  Darcy Shaw; Mustafa al'Absi
Journal:  Pharmacol Biochem Behav       Date:  2008-04-03       Impact factor: 3.533

2.  Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys.

Authors:  S S Negus; M B Gatch; N K Mello; X Zhang; K Rice
Journal:  J Pharmacol Exp Ther       Date:  1998-07       Impact factor: 4.030

3.  Changes at multiple levels of the hypothalamo-pituitary adrenal axis following repeated electrically induced seizures.

Authors:  E A Young; R L Spencer; B S McEwen
Journal:  Psychoneuroendocrinology       Date:  1990       Impact factor: 4.905

Review 4.  Pharmacologic treatments of cocaine abuse.

Authors:  F Gawin; H Kleber
Journal:  Psychiatr Clin North Am       Date:  1986-09

Review 5.  Reward processing by the opioid system in the brain.

Authors:  Julie Le Merrer; Jérôme A J Becker; Katia Befort; Brigitte L Kieffer
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

6.  Vernonia cinerea Less. supplementation and strenuous exercise reduce smoking rate: relation to oxidative stress status and beta-endorphin release in active smokers.

Authors:  Donrawee Leelarungrayub; Sainatee Pratanaphon; Prapas Pothongsunun; Thanyaluck Sriboonreung; Araya Yankai; Richard J Bloomer
Journal:  J Int Soc Sports Nutr       Date:  2010-05-26       Impact factor: 5.150

7.  Dopamine-dependent behavioural stimulation by non-peptide delta opioids BW373U86 and SNC 80: 2. Place-preference and brain microdialysis studies in rats.

Authors:  R Longoni; C Cadoni; A Mulas; G Di Chiara; L Spina
Journal:  Behav Pharmacol       Date:  1998-02       Impact factor: 2.293

Review 8.  Incubation of cocaine craving after withdrawal: a review of preclinical data.

Authors:  Lin Lu; Jeffrey W Grimm; Bruce T Hope; Yavin Shaham
Journal:  Neuropharmacology       Date:  2004       Impact factor: 5.250

9.  The selective non-peptidic delta opioid agonist SNC80 does not facilitate intracranial self-stimulation in rats.

Authors:  Gail Pereira Do Carmo; John E Folk; Kenner C Rice; Elena Chartoff; William A Carlezon; S Stevens Negus
Journal:  Eur J Pharmacol       Date:  2008-12-24       Impact factor: 4.432

10.  Rewarding properties of beta-endorphin as measured by conditioned place preference.

Authors:  M Amalric; E J Cline; J L Martinez; F E Bloom; G F Koob
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

View more
  15 in total

1.  High frequency deep transcranial magnetic stimulation acutely increases β-endorphins in obese humans.

Authors:  Anna Ferrulli; Concetta Macrì; Ileana Terruzzi; Federico Ambrogi; Valentina Milani; Michela Adamo; Livio Luzi
Journal:  Endocrine       Date:  2018-11-08       Impact factor: 3.633

2.  Combination of Levo-Tetrahydropalmatine and Low Dose Naltrexone: A Promising Treatment for Prevention of Cocaine Relapse.

Authors:  Sarah Sushchyk; Zheng-Xiong Xi; Jia Bei Wang
Journal:  J Pharmacol Exp Ther       Date:  2016-02-22       Impact factor: 4.030

Review 3.  The opioid receptors as targets for drug abuse medication.

Authors:  Florence Noble; Magalie Lenoir; Nicolas Marie
Journal:  Br J Pharmacol       Date:  2015-06-26       Impact factor: 8.739

4.  MP1104, a mixed kappa-delta opioid receptor agonist has anti-cocaine properties with reduced side-effects in rats.

Authors:  Diana V Atigari; Rajendra Uprety; Gavril W Pasternak; Susruta Majumdar; Bronwyn M Kivell
Journal:  Neuropharmacology       Date:  2019-02-13       Impact factor: 5.250

Review 5.  Recent advances on the δ opioid receptor: from trafficking to function.

Authors:  Louis Gendron; Nitish Mittal; Hélène Beaudry; Wendy Walwyn
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 6.  Novel approaches for the treatment of psychostimulant and opioid abuse - focus on opioid receptor-based therapies.

Authors:  Chris P Bailey; Stephen M Husbands
Journal:  Expert Opin Drug Discov       Date:  2014-09-25       Impact factor: 6.098

Review 7.  Role of cues and contexts on drug-seeking behaviour.

Authors:  Christina J Perry; Isabel Zbukvic; Jee Hyun Kim; Andrew J Lawrence
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

Review 8.  Molecular Pharmacology of δ-Opioid Receptors.

Authors:  Louis Gendron; Catherine M Cahill; Mark von Zastrow; Peter W Schiller; Graciela Pineyro
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

Review 9.  Synaptic mechanisms underlying persistent cocaine craving.

Authors:  Marina E Wolf
Journal:  Nat Rev Neurosci       Date:  2016-05-06       Impact factor: 34.870

Review 10.  The Nociceptin Receptor as an Emerging Molecular Target for Cocaine Addiction.

Authors:  Kabirullah Lutfy; Nurulain T Zaveri
Journal:  Prog Mol Biol Transl Sci       Date:  2015-12-23       Impact factor: 3.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.